BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 15907369)

  • 21. Gastrointestinal peptide signalling in health and disease.
    Rozengurt E; Guha S; Sinnett-Smith J
    Eur J Surg Suppl; 2002; (587):23-38. PubMed ID: 16144198
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of protein kinase C isoforms in modulating injury and repair of the intestinal barrier.
    Farhadi A; Keshavarzian A; Ranjbaran Z; Fields JZ; Banan A
    J Pharmacol Exp Ther; 2006 Jan; 316(1):1-7. PubMed ID: 16002462
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protein kinase C activation and its role in kidney disease.
    Li J; Gobe G
    Nephrology (Carlton); 2006 Oct; 11(5):428-34. PubMed ID: 17014557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exploitation of protein kinase C: a useful target for cancer therapy.
    Ali AS; Ali S; El-Rayes BF; Philip PA; Sarkar FH
    Cancer Treat Rev; 2009 Feb; 35(1):1-8. PubMed ID: 18778896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential effects of protein kinase C isoform activation in endothelin-mediated myocyte contractile dysfunction with cardioplegic arrest and reperfusion.
    Apple KA; McLean JE; Squires CE; Schaeffer B; Sample JA; Murphy RL; Deschamps AM; Leonardi AH; Allen CM; Hendrick JW; Stroud RE; Mukherjee R; Spinale FG
    Ann Thorac Surg; 2006 Aug; 82(2):664-71. PubMed ID: 16863782
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of peroxisome proliferator-activated receptor alpha by protein kinase C.
    Gray JP; Burns KA; Leas TL; Perdew GH; Vanden Heuvel JP
    Biochemistry; 2005 Aug; 44(30):10313-21. PubMed ID: 16042408
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of protein kinase C and role in cancer biology.
    Blobe GC; Obeid LM; Hannun YA
    Cancer Metastasis Rev; 1994 Dec; 13(3-4):411-31. PubMed ID: 7712599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protein kinase C epsilon is a predictive biomarker of aggressive breast cancer and a validated target for RNA interference anticancer therapy.
    Pan Q; Bao LW; Kleer CG; Sabel MS; Griffith KA; Teknos TN; Merajver SD
    Cancer Res; 2005 Sep; 65(18):8366-71. PubMed ID: 16166314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The regulation of glycine transporter GLYT1 is mainly mediated by protein kinase Calpha in C6 glioma cells.
    Morioka N; Abdin JM; Morita K; Kitayama T; Nakata Y; Dohi T
    Neurochem Int; 2008 Dec; 53(6-8):248-54. PubMed ID: 18778746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential roles of PKC-theta in the regulation of intracellular calcium concentration in primary T cells.
    Manicassamy S; Sadim M; Ye RD; Sun Z
    J Mol Biol; 2006 Jan; 355(3):347-59. PubMed ID: 16309697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Helicobacter pylori activates protein kinase C delta to control Raf in MAP kinase signalling: role in AGS epithelial cell scattering and elongation.
    Brandt S; Wessler S; Hartig R; Backert S
    Cell Motil Cytoskeleton; 2009 Oct; 66(10):874-92. PubMed ID: 19437514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conventional protein kinase C isoenzymes undergo dephosphorylation in neutrophil-like HL-60 cells treated by chelerythrine or sanguinarine.
    Vrba J; Dvorák Z; Ulrichová J; Modrianský M
    Cell Biol Toxicol; 2008 Jan; 24(1):39-53. PubMed ID: 17610032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of patterns of expression of protein kinase C-alpha, -delta, -eta, -gamma and -zeta and their correlations to p53, galectin-3, the retinoic acid receptor-beta and the macrophage migration inhibitory factor (MIF) in human cholesteatomas.
    Ghanooni R; Decaestecker C; Simon P; Gabius HJ; Hassid S; Choufani G
    Hear Res; 2006 Apr; 214(1-2):7-16. PubMed ID: 16513304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isoform-specific translocation of PKC isoforms in NIH3T3 cells by TPA.
    Kazi JU; Soh JW
    Biochem Biophys Res Commun; 2007 Dec; 364(2):231-7. PubMed ID: 17942077
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Activation mechanisms of protein kinase Czeta and its cellular function].
    Xu SJ; Cong B
    Sheng Li Ke Xue Jin Zhan; 2005 Oct; 36(4):309-13. PubMed ID: 16408768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protein kinase C inhibitors alter neurotensin receptor binding and function in prostate cancer PC3 cells.
    Carraway RE; Hassan S; Dobner PR
    Regul Pept; 2008 Apr; 147(1-3):96-109. PubMed ID: 18313772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protein kinase C (PKC) isoforms in cancer, tumor promotion and tumor suppression.
    Isakov N
    Semin Cancer Biol; 2018 Feb; 48():36-52. PubMed ID: 28571764
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of Transcriptional Networks by PKC Isozymes: Identification of c-Rel as a Key Transcription Factor for PKC-Regulated Genes.
    Garg R; Caino MC; Kazanietz MG
    PLoS One; 2013; 8(6):e67319. PubMed ID: 23826267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protein kinase C isoforms: Multi-functional regulators of cell life and death.
    Reyland ME
    Front Biosci (Landmark Ed); 2009 Jan; 14(6):2386-99. PubMed ID: 19273207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protein kinase C: is its pivotal role in cellular activation over-stated?
    Wilkinson SE; Hallam TJ
    Trends Pharmacol Sci; 1994 Feb; 15(2):53-7. PubMed ID: 8165725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.